Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.

Autor: Chang, Shih-Ching1 (AUTHOR), Liew, Phui-Ly2,3 (AUTHOR), Ansar, Muhamad4 (AUTHOR), Lin, Shih-Yun5 (AUTHOR), Wang, Sheng-Chao6 (AUTHOR), Hung, Chin-Sheng7,8 (AUTHOR), Chen, Jian-Yu9 (AUTHOR), Jain, Shikha4 (AUTHOR), Lin, Ruo-Kai4,5,6,10,11 (AUTHOR) linruokai@tmu.edu.tw
Zdroj: Clinical Epigenetics. 5/12/2020, Vol. 12 Issue 1, p1-17. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje